These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. High voltage immunoelectron microscopy of complement receptor type 3-mediated capping and internalization of group A streptococcal cell walls by human neutrophils. Pryzwansky KB Microsc Res Tech; 1994 Jul; 28(4):263-76. PubMed ID: 7919517 [TBL] [Abstract][Full Text] [Related]
3. Capping of complement receptors on human neutrophils induced by group A streptococcal cell walls. Pryzwansky KB; MacRae EK; Lambris JD J Immunol; 1983 Apr; 130(4):1674-7. PubMed ID: 6833750 [TBL] [Abstract][Full Text] [Related]
4. Opsonization of encapsulated Staphylococcus aureus: the role of specific antibody and complement. Verbrugh HA; Peterson PK; Nguyen BY; Sisson SP; Kim Y J Immunol; 1982 Oct; 129(4):1681-7. PubMed ID: 7108223 [TBL] [Abstract][Full Text] [Related]
5. Complement-independent adherence of Escherichia coli to complement receptors in vitro. Fine DP; Harper BL; Carpenter ED; Davis CP; Cavallo T; Guckian JC J Clin Invest; 1980 Sep; 66(3):465-72. PubMed ID: 6105165 [TBL] [Abstract][Full Text] [Related]
6. Interaction of group A streptococcal peptidoglycan polysaccharide with human polymorphonuclear leukocytes: implications for pathogenesis of chronic inflammation. Leong PA; Schwab JH; Cohen MS Infect Immun; 1984 Jul; 45(1):160-5. PubMed ID: 6329955 [TBL] [Abstract][Full Text] [Related]
7. Effect of muralytic enzyme degradation of streptococcal cell wall on complement activation in vivo and in vitro. Janusz MJ; Eisenberg RA; Schwab JH Inflammation; 1987 Mar; 11(1):73-85. PubMed ID: 3552978 [TBL] [Abstract][Full Text] [Related]
8. Group A streptococcal peptidoglycan-polysaccharide inhibits phagocytic activity of human polymorphonuclear leukocytes. Leong PA; Cohen MS Infect Immun; 1984 Aug; 45(2):378-83. PubMed ID: 6378796 [TBL] [Abstract][Full Text] [Related]
9. Xenoantiserum to human C3 receptors: its preparation and effect on the C3b and C3d receptors of tonsil cells and the C3b receptors of erythrocytes and neutrophils. Gerdes J; Klatt U; Stein H Immunology; 1980 Jan; 39(1):75-84. PubMed ID: 6991397 [TBL] [Abstract][Full Text] [Related]
10. Quantitation of the third component of human complement attached to the surface of opsonized bacteria: opsonin-deficient sera and phagocytosis-resistant strains. Verbrugh HA; van Dijk WC; van Erne ME; Peters R; Peterson PK; Verhoef J Infect Immun; 1979 Dec; 26(3):808-14. PubMed ID: 393633 [TBL] [Abstract][Full Text] [Related]
11. Defective complement receptors (CR1 and CR3) on erythrocytes and leukocytes of factor I (C3b-inactivator) deficient patients. Porteu F; Fischer A; Descamps-Latscha B; Halbwachs-Mecarelli L Clin Exp Immunol; 1986 Nov; 66(2):463-71. PubMed ID: 2949901 [TBL] [Abstract][Full Text] [Related]
12. Role of complements C3 and C5 in the phagocytosis of liposomes by human neutrophils. Scieszka JF; Maggiora LL; Wright SD; Cho MJ Pharm Res; 1991 Jan; 8(1):65-9. PubMed ID: 1826557 [TBL] [Abstract][Full Text] [Related]
13. Binding of C-reactive protein to the pneumococcal capsule or cell wall results in differential localization of C3 and stimulation of phagocytosis. Holzer TJ; Edwards KM; Gewurz H; Mold C J Immunol; 1984 Sep; 133(3):1424-30. PubMed ID: 6747291 [TBL] [Abstract][Full Text] [Related]
14. Complement component C3 fixes selectively to the major outer membrane protein (MOMP) of Legionella pneumophila and mediates phagocytosis of liposome-MOMP complexes by human monocytes. Bellinger-Kawahara C; Horwitz MA J Exp Med; 1990 Oct; 172(4):1201-10. PubMed ID: 2212949 [TBL] [Abstract][Full Text] [Related]
15. The key role of peptidoglycan in the opsonization of Staphylococcus aureus. Peterson PK; Wilkinson BJ; Kim Y; Schmeling D; Douglas SD; Quie PG; Verhoef J J Clin Invest; 1978 Mar; 61(3):597-609. PubMed ID: 641141 [TBL] [Abstract][Full Text] [Related]
16. Role of complement receptor type three and serum opsonins in the neutrophil response to yeast. Cain JA; Newman SL; Ross GD Complement; 1987; 4(2):75-86. PubMed ID: 3040333 [TBL] [Abstract][Full Text] [Related]
17. Inhibition of phagocytosis of complement C3- or immunoglobulin G-coated particles and of C3bi binding by monoclonal antibodies to a monocyte-granulocyte membrane glycoprotein (Mol). Arnaout MA; Todd RF; Dana N; Melamed J; Schlossman SF; Colten HR J Clin Invest; 1983 Jul; 72(1):171-9. PubMed ID: 6874946 [TBL] [Abstract][Full Text] [Related]
18. Cryptic peptidoglycan and the antiphagocytic effect of the Staphylococcus aureus capsule: model for the antiphagocytic effect of bacterial cell surface polymers. Wilkinson BJ; Peterson PK; Quie PG Infect Immun; 1979 Feb; 23(2):502-8. PubMed ID: 422250 [TBL] [Abstract][Full Text] [Related]
19. Analysis of the different types of leukocyte membrane complement receptors and their interaction with the complement system. Ross GD J Immunol Methods; 1980; 37(3-4):197-211. PubMed ID: 7005344 [TBL] [Abstract][Full Text] [Related]
20. Phagocytosis of leprosy bacilli is mediated by complement receptors CR1 and CR3 on human monocytes and complement component C3 in serum. Schlesinger LS; Horwitz MA J Clin Invest; 1990 Apr; 85(4):1304-14. PubMed ID: 2138634 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]